Asia Pacific Pharma ADMET Testing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others) 

No. of Pages: 136    |    Report Code: BMIRE00027311    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Pharma ADMET Testing Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Pharma ADMET Testing Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Pharma ADMET Testing Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increased demand for drug development
  • 5.1.2 Growth in pharmaceutical R&D investments
  • 5.1.3 Focus on reducing drug failure rates
5.2 Market Opportunities
  • 5.2.1 Adoption of AI in drug testing
  • 5.2.2 Growth in biologics and biosimilars testing
  • 5.2.3 Increasing outsourcing of ADMET testing
5.3 Future Trends
  • 5.3.1 Shift toward personalized medicine testing
  • 5.3.2 Development of high-throughput screening methods
  • 5.3.3 Focus on predictive toxicology
5.4 Impact of Drivers and Restraints

6. Asia Pacific Pharma ADMET Testing Market Regional Analysis

6.1 Asia Pacific Pharma ADMET Testing Market Overview
6.2 Asia Pacific Pharma ADMET Testing Market Revenue 2020-2028 (US$ Million)
6.3 Asia Pacific Pharma ADMET Testing Market Forecast Analysis

7. Asia Pacific Pharma ADMET Testing Market Analysis – by Testing Type

7.1 In Vivo ADMET Testing
  • 7.1.1 Overview
  • 7.1.2 In Vivo ADMET Testing: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 In Vitro ADMET Testing
  • 7.2.1 Overview
  • 7.2.2 In Vitro ADMET Testing: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 In Silico ADMET Testing
  • 7.3.1 Overview
  • 7.3.2 In Silico ADMET Testing: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Pharma ADMET Testing Market Analysis – by Technology

8.1 Cell Culture
  • 8.1.1 Overview
  • 8.1.2 Cell Culture: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
8.2 High Throughput
  • 8.2.1 Overview
  • 8.2.2 High Throughput: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Molecular Imaging
  • 8.3.1 Overview
  • 8.3.2 Molecular Imaging: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 OMICS Technology
  • 8.4.1 Overview
  • 8.4.2 OMICS Technology: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Pharma ADMET Testing Market Analysis – by Application

9.1 Systemic Toxicity
  • 9.1.1 Overview
  • 9.1.2 OMICS Technology: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Renal Toxicity
  • 9.2.1 Overview
  • 9.2.2 OMICS Technology: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Hepatotoxicity
  • 9.3.1 Overview
  • 9.3.2 OMICS Technology: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Neurotoxicity
  • 9.4.1 Overview
  • 9.4.2 OMICS Technology: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Pharma ADMET Testing Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Pharma ADMET Testing Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Pharma ADMET Testing Market Breakdown, by Testing Type
    • 10.1.1.1.2 China: Asia Pacific Pharma ADMET Testing Market Breakdown, by Technology
    • 10.1.1.1.3 China: Asia Pacific Pharma ADMET Testing Market Breakdown, by Application
  • 10.1.1.2 India: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Pharma ADMET Testing Market Breakdown, by Testing Type
    • 10.1.1.2.2 India: Asia Pacific Pharma ADMET Testing Market Breakdown, by Technology
    • 10.1.1.2.3 India: Asia Pacific Pharma ADMET Testing Market Breakdown, by Application
  • 10.1.1.3 Japan: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Pharma ADMET Testing Market Breakdown, by Testing Type
    • 10.1.1.3.2 Japan: Asia Pacific Pharma ADMET Testing Market Breakdown, by Technology
    • 10.1.1.3.3 Japan: Asia Pacific Pharma ADMET Testing Market Breakdown, by Application
  • 10.1.1.4 Australia: Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Pharma ADMET Testing Market Breakdown, by Testing Type
    • 10.1.1.4.2 Australia: Asia Pacific Pharma ADMET Testing Market Breakdown, by Technology
    • 10.1.1.4.3 Australia: Asia Pacific Pharma ADMET Testing Market Breakdown, by Application
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Pharma ADMET Testing Market Breakdown, by Testing Type
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Pharma ADMET Testing Market Breakdown, by Technology
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Pharma ADMET Testing Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Pharma ADMET Testing Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Agilent Technologies, Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bio-Rad Laboratories, Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Biovia (Dassault Systèmes)
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Charles River Laboratories
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 IQVIA Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 MERCK KGaA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Promega Corporation
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Wuxi AppTec
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

  1. Agilent Technologies, Inc.
  2. Bio-Rad Laboratories, Inc.
  3. Biovia (Dassault Systèmes)
  4. Charles River Laboratories
  5. IQVIA Inc.
  6. MERCK KGaA
  7. Promega Corporation
  8. Wuxi AppTec
asia-pacific-pharma-admet-testing-market